Report Detail
Global Preimplantation Genetic Diagnosis (PGD) Market Size, Status and Forecast 2020-2026
- RnM4095322 |
- 13 July, 2020 |
- Global |
- 133 Pages |
- QYResearch |
- Other
Preimplantation Genetic Diagnosis (PGD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetic Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Chromosomal Abnormalities
Gender Selection
X-linked Diseases
Aneuploidy
Single Gene Disorders
Others
Market segment by Application, split into
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
Based on regional and country-level analysis, the Preimplantation Genetic Diagnosis (PGD) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Preimplantation Genetic Diagnosis (PGD) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Illumina
Thermo Fisher
Agilent Technologies
PerkinElmer
Coopersurgical
Abbott Laboratories
Natera
Takara Bio
Oxford Gene Technology
Yikon Genomics
Progenesis
Beijing Genomics Institute
Invitae
Invicta Genetics
Combimatrix
Genea Limited
Bioarray
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Chromosomal Abnormalities
- 1.2.3 Gender Selection
- 1.2.4 X-linked Diseases
- 1.2.5 Aneuploidy
- 1.2.6 Single Gene Disorders
- 1.2.7 Others
- 1.3 Market by Application
- 1.3.1 Global Preimplantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2026
- 1.3.2 Maternity Centers & Fertility Clinics
- 1.3.3 Hospitals, Diagnostic Labs, and Service Providers
- 1.3.4 Research Laboratories & Academic Institutes
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Preimplantation Genetic Diagnosis (PGD) Market Perspective (2015-2026)
- 2.2 Global Preimplantation Genetic Diagnosis (PGD) Growth Trends by Regions
- 2.2.1 Preimplantation Genetic Diagnosis (PGD) Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Preimplantation Genetic Diagnosis (PGD) Historic Market Share by Regions (2015-2020)
- 2.2.3 Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Preimplantation Genetic Diagnosis (PGD) Players by Market Size
- 3.1.1 Global Top Preimplantation Genetic Diagnosis (PGD) Players by Revenue (2015-2020)
- 3.1.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2015-2020)
- 3.2 Global Preimplantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Preimplantation Genetic Diagnosis (PGD) Revenue
- 3.4 Global Preimplantation Genetic Diagnosis (PGD) Market Concentration Ratio
- 3.4.1 Global Preimplantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnosis (PGD) Revenue in 2019
- 3.5 Key Players Preimplantation Genetic Diagnosis (PGD) Area Served
- 3.6 Key Players Preimplantation Genetic Diagnosis (PGD) Product Solution and Service
- 3.7 Date of Enter into Preimplantation Genetic Diagnosis (PGD) Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetic Diagnosis (PGD) Breakdown Data by Type (2015-2026)
- 4.1 Global Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Type (2015-2020)
- 4.2 Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2021-2026)
5 Preimplantation Genetic Diagnosis (PGD) Breakdown Data by Application (2015-2026)
- 5.1 Global Preimplantation Genetic Diagnosis (PGD) Historic Market Size by Application (2015-2020)
- 5.2 Global Preimplantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Preimplantation Genetic Diagnosis (PGD) Market Size (2015-2026)
- 6.2 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
- 6.3 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)
- 6.4 North America Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Preimplantation Genetic Diagnosis (PGD) Market Size (2015-2026)
- 7.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
- 7.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)
- 7.4 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Preimplantation Genetic Diagnosis (PGD) Market Size (2015-2026)
- 8.2 China Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
- 8.3 China Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)
- 8.4 China Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Preimplantation Genetic Diagnosis (PGD) Market Size (2015-2026)
- 9.2 Japan Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
- 9.3 Japan Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)
- 9.4 Japan Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size (2015-2026)
- 10.2 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
- 10.3 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)
- 10.4 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 Illumina
- 11.1.1 Illumina Company Details
- 11.1.2 Illumina Business Overview
- 11.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.1.4 Illumina Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020))
- 11.1.5 Illumina Recent Development
- 11.2 Thermo Fisher
- 11.2.1 Thermo Fisher Company Details
- 11.2.2 Thermo Fisher Business Overview
- 11.2.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.2.4 Thermo Fisher Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.2.5 Thermo Fisher Recent Development
- 11.3 Agilent Technologies
- 11.3.1 Agilent Technologies Company Details
- 11.3.2 Agilent Technologies Business Overview
- 11.3.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.3.5 Agilent Technologies Recent Development
- 11.4 PerkinElmer
- 11.4.1 PerkinElmer Company Details
- 11.4.2 PerkinElmer Business Overview
- 11.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.4.4 PerkinElmer Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.4.5 PerkinElmer Recent Development
- 11.5 Coopersurgical
- 11.5.1 Coopersurgical Company Details
- 11.5.2 Coopersurgical Business Overview
- 11.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.5.4 Coopersurgical Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.5.5 Coopersurgical Recent Development
- 11.6 Abbott Laboratories
- 11.6.1 Abbott Laboratories Company Details
- 11.6.2 Abbott Laboratories Business Overview
- 11.6.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.6.4 Abbott Laboratories Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.6.5 Abbott Laboratories Recent Development
- 11.7 Natera
- 11.7.1 Natera Company Details
- 11.7.2 Natera Business Overview
- 11.7.3 Natera Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.7.4 Natera Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.7.5 Natera Recent Development
- 11.8 Takara Bio
- 11.8.1 Takara Bio Company Details
- 11.8.2 Takara Bio Business Overview
- 11.8.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.8.4 Takara Bio Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.8.5 Takara Bio Recent Development
- 11.9 Oxford Gene Technology
- 11.9.1 Oxford Gene Technology Company Details
- 11.9.2 Oxford Gene Technology Business Overview
- 11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.9.5 Oxford Gene Technology Recent Development
- 11.10 Yikon Genomics
- 11.10.1 Yikon Genomics Company Details
- 11.10.2 Yikon Genomics Business Overview
- 11.10.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Introduction
- 11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 11.10.5 Yikon Genomics Recent Development
- 11.11 Progenesis
- 10.11.1 Progenesis Company Details
- 10.11.2 Progenesis Business Overview
- 10.11.3 Progenesis Preimplantation Genetic Diagnosis (PGD) Introduction
- 10.11.4 Progenesis Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 10.11.5 Progenesis Recent Development
- 11.12 Beijing Genomics Institute
- 10.12.1 Beijing Genomics Institute Company Details
- 10.12.2 Beijing Genomics Institute Business Overview
- 10.12.3 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Introduction
- 10.12.4 Beijing Genomics Institute Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 10.12.5 Beijing Genomics Institute Recent Development
- 11.13 Invitae
- 10.13.1 Invitae Company Details
- 10.13.2 Invitae Business Overview
- 10.13.3 Invitae Preimplantation Genetic Diagnosis (PGD) Introduction
- 10.13.4 Invitae Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 10.13.5 Invitae Recent Development
- 11.14 Invicta Genetics
- 10.14.1 Invicta Genetics Company Details
- 10.14.2 Invicta Genetics Business Overview
- 10.14.3 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Introduction
- 10.14.4 Invicta Genetics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 10.14.5 Invicta Genetics Recent Development
- 11.15 Combimatrix
- 10.15.1 Combimatrix Company Details
- 10.15.2 Combimatrix Business Overview
- 10.15.3 Combimatrix Preimplantation Genetic Diagnosis (PGD) Introduction
- 10.15.4 Combimatrix Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 10.15.5 Combimatrix Recent Development
- 11.16 Genea Limited
- 10.16.1 Genea Limited Company Details
- 10.16.2 Genea Limited Business Overview
- 10.16.3 Genea Limited Preimplantation Genetic Diagnosis (PGD) Introduction
- 10.16.4 Genea Limited Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 10.16.5 Genea Limited Recent Development
- 11.17 Bioarray
- 10.17.1 Bioarray Company Details
- 10.17.2 Bioarray Business Overview
- 10.17.3 Bioarray Preimplantation Genetic Diagnosis (PGD) Introduction
- 10.17.4 Bioarray Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 10.17.5 Bioarray Recent Development
- 11.18 Quest Diagnostics
- 10.18.1 Quest Diagnostics Company Details
- 10.18.2 Quest Diagnostics Business Overview
- 10.18.3 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Introduction
- 10.18.4 Quest Diagnostics Revenue in Preimplantation Genetic Diagnosis (PGD) Business (2015-2020)
- 10.18.5 Quest Diagnostics Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Preimplantation Genetic Diagnosis (PGD). Industry analysis & Market Report on Preimplantation Genetic Diagnosis (PGD) is a syndicated market report, published as Global Preimplantation Genetic Diagnosis (PGD) Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Preimplantation Genetic Diagnosis (PGD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
